Pushing Boundries in Blood Micro-Analysis 

Horiba Medical, specialists in automated in vitro diagnostic systems for haematology and chemistry analysis, has launched the Microsemi CRP haematology analyser. Developed by Horiba Medical in Japan, ‘emi’ means ‘smile’ in Japanese and stands for easy to use, maintenance free and intelligent. After a highly successful release in Japan, this unique instrument is now available in Europe. This compact, easy-to-use addition to the Micros range simultaneously provides a complete blood count (CBC) and C-reactive protein (CRP) from just 18μl of blood - all in just 4 minutes.

The Microsemi CRP provides information of great clinical value enabling quicker and more accurate medical decisions to ultimately reduce hospitalisation times and patient costs. Its powerful CRP analysis allows the screening of patient samples to detect the presence of inflammation caused by bacterial infections, or other treatable inflammatory disease. Measurement is possible immediately after blood sample collection, making this analyser the ideal choice for emergency testing situations. The Microsemi CRP can also be used to assess infection and inflammatory conditions that require progressive observation. Furthermore, its micro-sampling capabilities are ideal for paediatric blood analysis, requiring just 10µL for CBC and 18µL for CBC+CRP, and can be used with capillary, as well as venous blood samples.

Comprehensive and efficient on-board software, colour touch screen, alongside fast and easy access to results adds to the Microsemi CRP’s success. Design features have created an environmentally-friendly model (using a non-cyanide reagent for haemoglobin measurement) that is incredibly compact, lightweight and quiet. The Microsemi CRP is easy to use and does not require specialised staff. All these traits make this analyser well-equipped to support changes occurring within the NHS focussed on easing the patient journey.

According to Cleve Wright, UK General Manager, Horiba Medical: “With over 2000 instruments successfully being used in Japan to date, UK clinicians can now benefit from the Microsemi CRP’s accuracy, convenience and ability to support early and rapid diagnosis of patients.”